Table of Contents
Global Sickle Cell Disease Drug Market Research Report 2021
1 Sickle Cell Disease Drug Market Overview
1.1 Product Overview and Scope of Sickle Cell Disease Drug
1.2 Sickle Cell Disease Drug Segment by Type (Product Category)
1.2.1 Global Sickle Cell Disease Drug Production and CAGR (%) Comparison by Type (Product Category)(2016 - 2027)
1.2.2 Global Sickle Cell Disease Drug Production Market Share by Type (Product Category) in 2017
1.2.3 ARQ - 092
1.2.4 BIVV - 003
1.2.5 CAL - H
1.2.6 CTX - 001
1.2.7 DRX - 194
1.2.8 Others
1.3 Global Sickle Cell Disease Drug Segment by Application
1.3.1 Sickle Cell Disease Drug Consumption (Sales) Comparison by Application (2016 - 2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Sickle Cell Disease Drug Market by Region (2016 - 2027)
1.4.1 Global Sickle Cell Disease Drug Market Size (Value) and CAGR (%) Comparison by Region (2016 - 2027)
1.4.2 North America Status and Prospect (2016 - 2027)
1.4.3 Europe Status and Prospect (2016 - 2027)
1.4.4 China Status and Prospect (2016 - 2027)
1.4.5 Japan Status and Prospect (2016 - 2027)
1.4.6 Southeast Asia Status and Prospect (2016 - 2027)
1.4.7 India Status and Prospect (2016 - 2027)
1.5 Global Market Size (Value) of Sickle Cell Disease Drug (2016 - 2027)
1.5.1 Global Sickle Cell Disease Drug Revenue Status and Outlook (2016 - 2027)
1.5.2 Global Sickle Cell Disease Drug Capacity, Production Status and Outlook (2016 - 2027)
2 Global Sickle Cell Disease Drug Market Competition by Manufacturers
2.1 Global Sickle Cell Disease Drug Capacity, Production and Share by Manufacturers (2016 - 2021)
2.1.1 Global Sickle Cell Disease Drug Capacity and Share by Manufacturers (2016 - 2021)
2.1.2 Global Sickle Cell Disease Drug Production and Share by Manufacturers (2016 - 2021)
2.2 Global Sickle Cell Disease Drug Revenue and Share by Manufacturers (2016 - 2021)
2.3 Global Sickle Cell Disease Drug Average Price by Manufacturers (2016 - 2021)
2.4 Manufacturers Sickle Cell Disease Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Sickle Cell Disease Drug Market Competitive Situation and Trends
2.5.1 Sickle Cell Disease Drug Market Concentration Rate
2.5.2 Sickle Cell Disease Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Sickle Cell Disease Drug Capacity, Production, Revenue (Value) by Region (2016 - 2021)
3.1 Global Sickle Cell Disease Drug Capacity and Market Share by Region (2016 - 2021)
3.2 Global Sickle Cell Disease Drug Production and Market Share by Region (2016 - 2021)
3.3 Global Sickle Cell Disease Drug Revenue (Value) and Market Share by Region (2016 - 2021)
3.4 Global Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
3.5 North America Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
3.6 Europe Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
3.7 China Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
3.8 Japan Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
3.9 Southeast Asia Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
3.10 India Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
4 Global Sickle Cell Disease Drug Supply (Production), Consumption, Export, Import by Region (2016 - 2021)
4.1 Global Sickle Cell Disease Drug Consumption by Region (2016 - 2021)
4.2 North America Sickle Cell Disease Drug Production, Consumption, Export, Import (2016 - 2021)
4.3 Europe Sickle Cell Disease Drug Production, Consumption, Export, Import (2016 - 2021)
4.4 China Sickle Cell Disease Drug Production, Consumption, Export, Import (2016 - 2021)
4.5 Japan Sickle Cell Disease Drug Production, Consumption, Export, Import (2016 - 2021)
4.6 Southeast Asia Sickle Cell Disease Drug Production, Consumption, Export, Import (2016 - 2021)
4.7 India Sickle Cell Disease Drug Production, Consumption, Export, Import (2016 - 2021)
5 Global Sickle Cell Disease Drug Production, Revenue (Value), Price Trend by Type
5.1 Global Sickle Cell Disease Drug Production and Market Share by Type (2016 - 2021)
5.2 Global Sickle Cell Disease Drug Revenue and Market Share by Type (2016 - 2021)
5.3 Global Sickle Cell Disease Drug Price by Type (2016 - 2021)
5.4 Global Sickle Cell Disease Drug Production Growth by Type (2016 - 2021)
6 Global Sickle Cell Disease Drug Market Analysis by Application
6.1 Global Sickle Cell Disease Drug Consumption and Market Share by Application (2016 - 2021)
6.2 Global Sickle Cell Disease Drug Consumption Growth Rate by Application (2016 - 2021)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Sickle Cell Disease Drug Manufacturers Profiles/Analysis
7.1 Acceleron Pharma Inc
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Sickle Cell Disease Drug Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Acceleron Pharma Inc Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.1.4 Main Business/Business Overview
7.2 Addmedica SAS
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Sickle Cell Disease Drug Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Addmedica SAS Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.2.4 Main Business/Business Overview
7.3 Angiocrine Bioscience Inc
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Sickle Cell Disease Drug Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Angiocrine Bioscience Inc Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.3.4 Main Business/Business Overview
7.4 Annexin Pharmaceuticals AB
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Sickle Cell Disease Drug Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.4.4 Main Business/Business Overview
7.5 ArQule Inc
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Sickle Cell Disease Drug Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 ArQule Inc Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2015 - 2021)
7.5.4 Main Business/Business Overview
7.6 Bio Products Laboratory Ltd
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Sickle Cell Disease Drug Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Bio Products Laboratory Ltd Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.6.4 Main Business/Business Overview
7.7 Bioverativ Inc
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Sickle Cell Disease Drug Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Bioverativ Inc Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.7.4 Main Business/Business Overview
7.8 bluebird bio Inc
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Sickle Cell Disease Drug Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 bluebird bio Inc Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.8.4 Main Business/Business Overview
7.9 Bristol - Myers Squibb Co
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Sickle Cell Disease Drug Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Bristol - Myers Squibb Co Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.9.4 Main Business/Business Overview
7.10 Calimmune Inc
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Sickle Cell Disease Drug Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Calimmune Inc Sickle Cell Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2020)
7.10.4 Main Business/Business Overview
7.11 CRISPR Therapeutics
7.12 CSL Ltd
7.13 Daiichi Sankyo Co Ltd
7.14 Editas Medicine Inc
7.15 Errant Gene Therapeutics LLC
7.16 Gamida Cell Ltd
7.17 Genethon SA
7.18 Gilead Sciences Inc
7.19 Global Blood Therapeutics Inc
8 Sickle Cell Disease Drug Manufacturing Cost Analysis
8.1 Sickle Cell Disease Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Sickle Cell Disease Drug
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Sickle Cell Disease Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Sickle Cell Disease Drug Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Sickle Cell Disease Drug Market Forecast (2021 - 2027)
12.1 Global Sickle Cell Disease Drug Capacity, Production, Revenue Forecast (2021 - 2027)
12.1.1 Global Sickle Cell Disease Drug Capacity, Production and Growth Rate Forecast (2021 - 2027)
12.1.2 Global Sickle Cell Disease Drug Revenue and Growth Rate Forecast (2021 - 2027)
12.1.3 Global Sickle Cell Disease Drug Price and Trend Forecast (2021 - 2027)
12.2 Global Sickle Cell Disease Drug Production, Consumption , Import and Export Forecast by Region (2021 - 2027)
12.2.1 North America Sickle Cell Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2021 - 2027)
12.2.2 Europe Sickle Cell Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2021 - 2027)
12.2.3 China Sickle Cell Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2021 - 2027)
12.2.4 Japan Sickle Cell Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2021 - 2027)
12.2.5 Southeast Asia Sickle Cell Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2021 - 2027)
12.2.6 India Sickle Cell Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2021 - 2027)
12.3 Global Sickle Cell Disease Drug Production, Revenue and Price Forecast by Type (2021 - 2027)
12.4 Global Sickle Cell Disease Drug Consumption Forecast by Application (2021 - 2027)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Sickle Cell Disease Drug
Figure Global Sickle Cell Disease Drug Production () and CAGR (%) Comparison by Types (Product Category) (2016 - 2027)
Figure Global Sickle Cell Disease Drug Production Market Share by Types (Product Category) in 2017
Figure Product Picture of ARQ - 092
Table Major Manufacturers of ARQ - 092
Figure Product Picture of BIVV - 003
Table Major Manufacturers of BIVV - 003
Figure Product Picture of CAL - H
Table Major Manufacturers of CAL - H
Figure Product Picture of CTX - 001
Table Major Manufacturers of CTX - 001
Figure Product Picture of DRX - 194
Table Major Manufacturers of DRX - 194
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Sickle Cell Disease Drug Consumption (K Pcs) by Applications (2016 - 2027)
Figure Global Sickle Cell Disease Drug Consumption Market Share by Applications in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Sickle Cell Disease Drug Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2016 - 2027)
Figure North America Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Europe Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure China Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Japan Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Southeast Asia Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure India Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Global Sickle Cell Disease Drug Revenue (Million USD) Status and Outlook (2016 - 2027)
Figure Global Sickle Cell Disease Drug Capacity, Production (K Pcs) Status and Outlook (2016 - 2027)
Figure Global Sickle Cell Disease Drug Major Players Product Capacity (K Pcs) (2016 - 2021)
Table Global Sickle Cell Disease Drug Capacity (K Pcs) of Key Manufacturers (2016 - 2021)
Table Global Sickle Cell Disease Drug Capacity Market Share of Key Manufacturers (2016 - 2021)
Figure Global Sickle Cell Disease Drug Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Sickle Cell Disease Drug Capacity (K Pcs) of Key Manufacturers in 2021
Figure Global Sickle Cell Disease Drug Major Players Product Production (K Pcs) (2016 - 2021)
Table Global Sickle Cell Disease Drug Production (K Pcs) of Key Manufacturers (2016 - 2021)
Table Global Sickle Cell Disease Drug Production Share by Manufacturers (2016 - 2021)
Figure 2017 Sickle Cell Disease Drug Production Share by Manufacturers
Figure 2017 Sickle Cell Disease Drug Production Share by Manufacturers
Figure Global Sickle Cell Disease Drug Major Players Product Revenue (Million USD) (2016 - 2021)
Table Global Sickle Cell Disease Drug Revenue (Million USD) by Manufacturers (2016 - 2021)
Table Global Sickle Cell Disease Drug Revenue Share by Manufacturers (2016 - 2021)
Table 2017 Global Sickle Cell Disease Drug Revenue Share by Manufacturers
Table 2021 Global Sickle Cell Disease Drug Revenue Share by Manufacturers
Table Global Market Sickle Cell Disease Drug Average Price (USD/Pcs) of Key Manufacturers (2016 - 2021)
Figure Global Market Sickle Cell Disease Drug Average Price (USD/Pcs) of Key Manufacturers in 2017
Table Manufacturers Sickle Cell Disease Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Sickle Cell Disease Drug Product Category
Figure Sickle Cell Disease Drug Market Share of Top 3 Manufacturers
Figure Sickle Cell Disease Drug Market Share of Top 5 Manufacturers
Table Global Sickle Cell Disease Drug Capacity (K Pcs) by Region (2016 - 2021)
Figure Global Sickle Cell Disease Drug Capacity Market Share by Region (2016 - 2021)
Figure Global Sickle Cell Disease Drug Capacity Market Share by Region (2016 - 2021)
Figure 2017 Global Sickle Cell Disease Drug Capacity Market Share by Region
Table Global Sickle Cell Disease Drug Production by Region (2016 - 2021)
Figure Global Sickle Cell Disease Drug Production (K Pcs) by Region (2016 - 2021)
Figure Global Sickle Cell Disease Drug Production Market Share by Region (2016 - 2021)
Figure 2017 Global Sickle Cell Disease Drug Production Market Share by Region
Table Global Sickle Cell Disease Drug Revenue (Million USD) by Region (2016 - 2021)
Table Global Sickle Cell Disease Drug Revenue Market Share by Region (2016 - 2021)
Figure Global Sickle Cell Disease Drug Revenue Market Share by Region (2016 - 2021)
Table 2017 Global Sickle Cell Disease Drug Revenue Market Share by Region
Figure Global Sickle Cell Disease Drug Capacity, Production (K Pcs) and Growth Rate (2016 - 2021)
Table Global Sickle Cell Disease Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016 - 2021)
Table North America Sickle Cell Disease Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016 - 2021)
Table Europe Sickle Cell Disease Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016 - 2021)
Table China Sickle Cell Disease Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016 - 2021)
Table Japan Sickle Cell Disease Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016 - 2021)
Table China Sickle Cell Disease Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016 - 2021)
Table Japan Sickle Cell Disease Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016 - 2021)
Table Global Sickle Cell Disease Drug Consumption (K Pcs) Market by Region (2016 - 2021)
Table Global Sickle Cell Disease Drug Consumption Market Share by Region (2016 - 2021)
Figure Global Sickle Cell Disease Drug Consumption Market Share by Region (2016 - 2021)
Figure 2017 Global Sickle Cell Disease Drug Consumption (K Pcs) Market Share by Region
Table North America Sickle Cell Disease Drug Production, Consumption, Import & Export (K Pcs) (2016 - 2021)
Table Europe Sickle Cell Disease Drug Production, Consumption, Import & Export (K Pcs) (2016 - 2021)
Table China Sickle Cell Disease Drug Production, Consumption, Import & Export (K Pcs) (2016 - 2021)
Table Japan Sickle Cell Disease Drug Production, Consumption, Import & Export (K Pcs) (2016 - 2021)
Table Southeast Asia Sickle Cell Disease Drug Production, Consumption, Import & Export (K Pcs) (2016 - 2021)
Table India Sickle Cell Disease Drug Production, Consumption, Import & Export (K Pcs)
